Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

45.49
-1.7650-3.74%
Volume:3.47M
Turnover:161.90M
Market Cap:7.56B
PE:-13.07
High:47.59
Open:47.20
Low:45.45
Close:47.25
52wk High:86.74
52wk Low:45.45
Shares:166.18M
Float Shares:161.92M
Volume Ratio:1.14
T/O Rate:2.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:17.19
PE(LYR):-19.10

Loading ...

Ionis Pharmaceuticals, Inc. : Jefferies Cuts Target Price to $88 from $90

THOMSON REUTERS
·
Sep 04

US FDA Approves Ionis Pharma's Therapy to Treat Rare Genetic Disorder

Reuters
·
Sep 04

FDA: Approves Zanvastro (Zilganersen) Injection for Treatment of Alexander Disease in Pediatric and Adult Patients

THOMSON REUTERS
·
Sep 04

Movement Alert|Ionis Pharmaceuticals Falls 5.06% in Regular Trading, Trading at $58.215

Market Focus
·
Sep 04

Ultragenyx Hits Record Low After Rare Disease Drug Trial Failure

Reuters
·
Sep 03

Ionis to Join Wells Fargo, Morgan Stanley Healthcare Investor Conference Fireside Chats

Reuters
·
Sep 03

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Ionis Pharmaceuticals Price Target Maintained with a $115.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 31

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Aug 31

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

TIPRANKS
·
Aug 28

Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment

Reuters
·
Aug 28

Ionis Pharmaceuticals, Inc. : Bmo Initiates Coverage with Market Perform Rating; Price Target $60

THOMSON REUTERS
·
Aug 19

BMO Capital starts Ionis at Market Perform pending better visibility

TIPRANKS
·
Aug 19

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)

TIPRANKS
·
Aug 15

Ionis Pharmaceuticals (IONS) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Ionis Pharmaceuticals Earnings Call Highlights Pipeline And Growth

TIPRANKS
·
Aug 12

J.P. Morgan Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Aug 10

Novartis Might Struggle to Clear Bar in Cholesterol Drug Trial

Dow Jones
·
Aug 10

Ionis Pharmaceuticals (IONS) Receives a Hold from Stifel Nicolaus

TIPRANKS
·
Aug 03

Ionis Director Michael R. Hayden Reports Acquisition of 20,000 Common Shares Worth $1,059,000

Reuters
·
Aug 01